Part B Drugs At Home: Medicare Policy Responds To COVID-Driven Access Concerns

 
• By Cathy Kelly
  
Intravenous drip
Instead of an intravenous drip, policy change in the coronavirus era has felt more like a bolus.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet